Stay updated on PD-L1+ NSCLC Coformulation vs Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the PD-L1+ NSCLC Coformulation vs Pembrolizumab Clinical Trial page.

Latest updates to the PD-L1+ NSCLC Coformulation vs Pembrolizumab Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe record now shows that the study is not enrolling participants, and the history includes a new revision (v3.6.0) replacing the prior revision (v3.5.5).SummaryDifference0.1%

- Check21 days agoChange DetectedThe history now includes a new latest revision tag v3.5.5, while the previous revision v3.5.4 is removed from the list.SummaryDifference0.0%

- Check42 days agoChange DetectedThe history now shows a new site revision, v3.5.4, replacing the prior v3.5.3. This indicates a small update to the page's release notes in the history log.SummaryDifference0.0%

- Check63 days agoChange DetectedA minor update to the ClinicalTrials.gov page revision/version label was applied (switching from v3.5.2 to v3.5.3). This reflects a site software/version change rather than a change to the trial’s recorded information.SummaryDifference0.0%

- Check70 days agoChange DetectedThe page now shows Revision: v3.5.2 and no longer displays Revision: v3.5.0.SummaryDifference0.0%

- Check99 days agoChange DetectedA new revision entry v3.5.0 was added to the page history, and v3.4.3 is shown as a deletion.SummaryDifference0.0%

Stay in the know with updates to PD-L1+ NSCLC Coformulation vs Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD-L1+ NSCLC Coformulation vs Pembrolizumab Clinical Trial page.